What is Medica?
Medica Corporation specializes in the development and manufacturing of user-friendly, highly reliable diagnostic blood testing analyzers. The company's core focus is on enhancing productivity and the quality of patient care within small to medium-sized in vitro diagnostic laboratories. Medica's product portfolio, which includes clinical chemistry, blood gas, and electrolyte analyzers, addresses the global imperative to reduce healthcare expenditures through efficient and accurate diagnostic solutions.
How much funding has Medica raised?
Medica has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Medica?
The recent major strategic investment signals a new phase of growth and development for Medica. This enterprise-level funding is expected to accelerate the company's innovation pipeline, potentially leading to the expansion of its technological capabilities and market reach. Medica is poised to further solidify its position by continuing to deliver advanced diagnostic tools that meet the evolving demands of the healthcare industry for cost-effectiveness and superior care.
See full Medica company page
